Dr Lalchandani Labs IPO

Dr Lalchandani Labs IPOBusiness description - Dr Lalchandani Labs is formed to set up, engage, collaborate, acquire, purchase, maintain, open collection centres, conduct, manage, administer, own, run laboratories for the purposes of carrying out pathological investigations of various branches of Bio-Chemistry, Hematology, Histopathology, Microbiology, Electrophoresis, , Virology, Cytology, other pathological Investigations and Immunoassay, Immuno-Histochemistry, Molecular Pathology, Dna & Genetic Testing etc. The company is a provider of diagnostic and related healthcare tests and services in Delhi/NCR. Through its integrated network, it offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. Its customers include individual patients, hospitals and other healthcare providers and corporate customers. The company is NABL Accredited Lab has established itself within Delhi/NCR with 5 (Five) Self-Sufficient Labs and multiple collection centers.

Promoters of Dr Lalchandani Labs – Mr Arjan Lal Chandani, Mr Mohit Lal Chandani and Mrs Anchal Gupta
Dr Lalchandani Labs IPO details
Subscription Dates 25 - 27 April 2018
IPO Price band INR30 per share
Fresh issue 1,400,000 shares (INR4.2 crore)
Offer for sale Nil
Total IPO size 1,400,000 shares (INR4.2 crore)
Minimum bid (lot size) 4,000 shares
Face Value  INR10 per share
Retail Allocation 50%
Listing On BSE SME platform
Use of funds
  • To open second major processing center (2000 sq. ft. area) in Delhi/NCR - INR0.35 crore
  • Repayment/pre-payment, in full or part, of certain borrowings - INR1.00 crore
  • To purchase advanced machinery and equipment - INR0.50 crore
  • To open new collection centers based on COCO model - INR0.27 crore
  • To Develop E- Applications and E Programs and other I.T. support system - INR0.11 crore
  • For Recruitment, Training and Placement of staff to expand operations and other operational expenses - INR0.62 crore
  • For general corporate purposes - INR1.00 crore
  • Issue Expenses - INR0.35 crore
Dr Lalchandani Labs' financial performance (in INR lakh)
FY2013 FY2014 FY2015 FY2016 FY2017
Total revenue 122.0 141.4 192.8 302.8 461.7
Total expenses 120.0 137.3 160.9 270.6 390.9
Profit after tax 1.9 4.1 31.9 32.2 70.7
Dr Lalchandani Labs' Contact Details

Dr Lalchandani Labs Limited
M-20 Basement
Greater Kailash-1
New Delhi 110 048

Phone: +91 011 4905 7058
Email: [email protected]
Website: www.lalchandanipathlab.com

Dr Lalchandani Labs IPO Subscription Details
Day Subscription (no. of times)
Day 1 0.22
Day 2 1.46
Day 3 4.44
Dr Lalchandani Labs Valuation (Latest FY)

Earnings Per Share (EPS): NA

Price/Earnings (P/E) ratio: NA

Return on Net Worth (RONW): NA

Net Asset Value (NAV): NA

Registrar of Dr Lalchandani Labs IPO

Cameo Corporate Services Limited
Subramanian Building, 1 Club House Road,
Chennai-600 002
Tamil Nadu, India

Phone: +91 44 2846 0390
Fax: +91 44 2846 0129
Email[email protected]
Website: http://www.cameoindia.com

Dr Lalchandani Labs IPO Allotment Status

Dr Lalchandani Labs IPO allotment status is now available on Cameo Corporate Services' website. Click on this link to get allotment status.

Listing performance of Dr Lalchandani Labs

IPO Opening Date: 25 April 2018

IPO Closing Date: 27 April 2018

Listing Date: 9 May 2018

Listing Price on BSE SME: INR29.95 per share (down 0.16% from IPO price)

Closing Price on BSE SME: INR28.50 per share (down 5% from IPO price)

Dr Lalchandani Labs IPO
Rate this post

One thought on “Dr Lalchandani Labs IPO

  • April 25, 2018 at 12:21 AM
    Permalink

    Sir what is your view ?

    Reply

Leave a Reply

Your email address will not be published. Required fields are marked *